カテゴリー： Market Monitor Global, 世界, 医療/バイオ

イオンチャネル型グルタミン酸受容体NMDA 2Bの世界市場見通し2023年-2029年

◆英語タイトル：Glutamate Receptor Ionotropic NMDA 2B Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5592）◆商品コード：MMG23JU5592
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：77
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Glutamate Receptor Ionotropic NMDA 2B Market 調査レポートは次の情報を含め、グローバルにおけるのイオンチャネル型グルタミン酸受容体NMDA 2B市場規模と予測を収録しています。・世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：売上、2018年-2023年、2024年-2029年
・世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「JNJ-0808」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

イオンチャネル型グルタミン酸受容体NMDA 2Bのグローバル主要企業は、BioCrea GmbH、 Bristol-Myers Squibb Company、 Cerecor Inc.、 Johnson & Johnson、 Luc Therapeutics, Inc.、 NeurOp, Inc、 Novartis AG、 UCB S.A.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、イオンチャネル型グルタミン酸受容体NMDA 2Bのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：タイプ別、2018年-2023年、2024年-2029年
世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：タイプ別市場シェア、2022年
・JNJ-0808、Neu-2000、NP-10679、NP-11948、ラジプロジル、その他

世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：用途別、2018年-2023年、2024年-2029年
世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：用途別市場シェア、2022年
・急性虚血性脳卒中、自閉症、脳虚血、やけど、その他

世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：地域・国別、2018年-2023年、2024年-2029年
世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるイオンチャネル型グルタミン酸受容体NMDA 2Bのグローバル売上、2018年-2023年
・主要企業におけるイオンチャネル型グルタミン酸受容体NMDA 2Bのグローバル売上シェア、2022年
・主要企業におけるイオンチャネル型グルタミン酸受容体NMDA 2Bのグローバル販売量、2018年-2023年
・主要企業におけるイオンチャネル型グルタミン酸受容体NMDA 2Bのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
BioCrea GmbH、 Bristol-Myers Squibb Company、 Cerecor Inc.、 Johnson & Johnson、 Luc Therapeutics, Inc.、 NeurOp, Inc、 Novartis AG、 UCB S.A.

*************************************************************

・調査・分析レポートの概要
イオンチャネル型グルタミン酸受容体NMDA 2B市場の定義
市場セグメント
世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場規模
世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場規模：2022年 VS 2029年
世界のイオンチャネル型グルタミン酸受容体NMDA 2B市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのイオンチャネル型グルタミン酸受容体NMDA 2Bの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のイオンチャネル型グルタミン酸受容体NMDA 2B製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：JNJ-0808、Neu-2000、NP-10679、NP-11948、ラジプロジル、その他
イオンチャネル型グルタミン酸受容体NMDA 2Bのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：急性虚血性脳卒中、自閉症、脳虚血、やけど、その他
イオンチャネル型グルタミン酸受容体NMDA 2Bの用途別グローバル売上・予測

・地域別市場分析
地域別イオンチャネル型グルタミン酸受容体NMDA 2B市場規模 2022年と2029年
地域別イオンチャネル型グルタミン酸受容体NMDA 2B売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
BioCrea GmbH、 Bristol-Myers Squibb Company、 Cerecor Inc.、 Johnson & Johnson、 Luc Therapeutics, Inc.、 NeurOp, Inc、 Novartis AG、 UCB S.A.
...

This report aims to provide a comprehensive presentation of the global market for Glutamate Receptor Ionotropic NMDA 2B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glutamate Receptor Ionotropic NMDA 2B. This report contains market size and forecasts of Glutamate Receptor Ionotropic NMDA 2B in global, including the following market information:
Global Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Glutamate Receptor Ionotropic NMDA 2B Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Glutamate Receptor Ionotropic NMDA 2B companies in 2022 (%)
The global Glutamate Receptor Ionotropic NMDA 2B market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
JNJ-0808 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Glutamate Receptor Ionotropic NMDA 2B include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glutamate Receptor Ionotropic NMDA 2B manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glutamate Receptor Ionotropic NMDA 2B Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, by Type, 2022 (%)
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Global Glutamate Receptor Ionotropic NMDA 2B Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, by Application, 2022 (%)
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
Global Glutamate Receptor Ionotropic NMDA 2B Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glutamate Receptor Ionotropic NMDA 2B revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glutamate Receptor Ionotropic NMDA 2B revenues share in global market, 2022 (%)
Key companies Glutamate Receptor Ionotropic NMDA 2B sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Glutamate Receptor Ionotropic NMDA 2B sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glutamate Receptor Ionotropic NMDA 2B, market overview.
Chapter 2: Global Glutamate Receptor Ionotropic NMDA 2B market size in revenue and volume.
Chapter 3: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glutamate Receptor Ionotropic NMDA 2B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glutamate Receptor Ionotropic NMDA 2B capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Glutamate Receptor Ionotropic NMDA 2B Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glutamate Receptor Ionotropic NMDA 2B Overall Market Size
2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size: 2022 VS 2029
2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales: 2018-2029
3 Company Landscape
3.1 Top Glutamate Receptor Ionotropic NMDA 2B Players in Global Market
3.2 Top Global Glutamate Receptor Ionotropic NMDA 2B Companies Ranked by Revenue
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Companies
3.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Companies
3.5 Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glutamate Receptor Ionotropic NMDA 2B Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glutamate Receptor Ionotropic NMDA 2B Players in Global Market
3.8.1 List of Global Tier 1 Glutamate Receptor Ionotropic NMDA 2B Companies
3.8.2 List of Global Tier 2 and Tier 3 Glutamate Receptor Ionotropic NMDA 2B Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Market Size Markets, 2022 & 2029
4.1.2 JNJ-0808
4.1.3 Neu-2000
4.1.4 NP-10679
4.1.5 NP-11948
4.1.6 Radiprodil
4.1.7 Others
4.2 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Revenue & Forecasts
4.2.1 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2023
4.2.2 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2024-2029
4.2.3 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
4.3 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Sales & Forecasts
4.3.1 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2023
4.3.2 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2024-2029
4.3.3 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
4.4 By Type – Global Glutamate Receptor Ionotropic NMDA 2B Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Market Size, 2022 & 2029
5.1.2 Acute Ischemic Stroke
5.1.3 Autism
5.1.4 Brain Ischemia
5.1.5 Burns
5.1.6 Others
5.2 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Revenue & Forecasts
5.2.1 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2023
5.2.2 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2024-2029
5.2.3 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
5.3 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Sales & Forecasts
5.3.1 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2023
5.3.2 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2024-2029
5.3.3 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
5.4 By Application – Global Glutamate Receptor Ionotropic NMDA 2B Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Market Size, 2022 & 2029
6.2 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Revenue & Forecasts
6.2.1 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2023
6.2.2 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2024-2029
6.2.3 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
6.3 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Sales & Forecasts
6.3.1 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2023
6.3.2 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2024-2029
6.3.3 By Region – Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2029
6.4.2 By Country – North America Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2029
6.4.3 US Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.4.4 Canada Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.4.5 Mexico Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2029
6.5.2 By Country – Europe Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2029
6.5.3 Germany Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.5.4 France Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.5.5 U.K. Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.5.6 Italy Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.5.7 Russia Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.5.8 Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.5.9 Benelux Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2029
6.6.2 By Region – Asia Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2029
6.6.3 China Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.6.4 Japan Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.6.5 South Korea Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.6.6 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.6.7 India Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2029
6.7.2 By Country – South America Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2029
6.7.3 Brazil Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.7.4 Argentina Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales, 2018-2029
6.8.3 Turkey Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.8.4 Israel Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.8.5 Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
6.8.6 UAE Glutamate Receptor Ionotropic NMDA 2B Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 BioCrea GmbH
7.1.1 BioCrea GmbH Company Summary
7.1.2 BioCrea GmbH Business Overview
7.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.1.5 BioCrea GmbH Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 Cerecor Inc.
7.3.1 Cerecor Inc. Company Summary
7.3.2 Cerecor Inc. Business Overview
7.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.3.5 Cerecor Inc. Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Luc Therapeutics, Inc.
7.5.1 Luc Therapeutics, Inc. Company Summary
7.5.2 Luc Therapeutics, Inc. Business Overview
7.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.5.5 Luc Therapeutics, Inc. Key News & Latest Developments
7.6 NeurOp, Inc
7.6.1 NeurOp, Inc Company Summary
7.6.2 NeurOp, Inc Business Overview
7.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.6.5 NeurOp, Inc Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.7.5 Novartis AG Key News & Latest Developments
7.8 UCB S.A.
7.8.1 UCB S.A. Company Summary
7.8.2 UCB S.A. Business Overview
7.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2018-2023)
7.8.5 UCB S.A. Key News & Latest Developments
8 Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity, Analysis
8.1 Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity, 2018-2029
8.2 Glutamate Receptor Ionotropic NMDA 2B Production Capacity of Key Manufacturers in Global Market
8.3 Global Glutamate Receptor Ionotropic NMDA 2B Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glutamate Receptor Ionotropic NMDA 2B Supply Chain Analysis
10.1 Glutamate Receptor Ionotropic NMDA 2B Industry Value Chain
10.2 Glutamate Receptor Ionotropic NMDA 2B Upstream Market
10.3 Glutamate Receptor Ionotropic NMDA 2B Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Glutamate Receptor Ionotropic NMDA 2B in Global Market
Table 2. Top Glutamate Receptor Ionotropic NMDA 2B Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Companies, 2018-2023
Table 5. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
Table 9. List of Global Tier 1 Glutamate Receptor Ionotropic NMDA 2B Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glutamate Receptor Ionotropic NMDA 2B Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), 2018-2023
Table 15. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), 2024-2029
Table 16. By Application – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), 2018-2023
Table 20. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), 2024-2029
Table 21. By Region – Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), 2018-2023
Table 25. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), 2024-2029
Table 26. By Country - North America Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales, (K Pcs), 2024-2029
Table 46. BioCrea GmbH Company Summary
Table 47. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 48. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. BioCrea GmbH Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Company Summary
Table 51. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 52. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Bristol-Myers Squibb Company Key News & Latest Developments
Table 54. Cerecor Inc. Company Summary
Table 55. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 56. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Cerecor Inc. Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 60. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Luc Therapeutics, Inc. Company Summary
Table 63. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 64. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Luc Therapeutics, Inc. Key News & Latest Developments
Table 66. NeurOp, Inc Company Summary
Table 67. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 68. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. NeurOp, Inc Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 72. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Novartis AG Key News & Latest Developments
Table 74. UCB S.A. Company Summary
Table 75. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Offerings
Table 76. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. UCB S.A. Key News & Latest Developments
Table 78. Glutamate Receptor Ionotropic NMDA 2B Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 79. Global Glutamate Receptor Ionotropic NMDA 2B Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Glutamate Receptor Ionotropic NMDA 2B Production by Region, 2018-2023 (K Pcs)
Table 81. Global Glutamate Receptor Ionotropic NMDA 2B Production by Region, 2024-2029 (K Pcs)
Table 82. Glutamate Receptor Ionotropic NMDA 2B Market Opportunities & Trends in Global Market
Table 83. Glutamate Receptor Ionotropic NMDA 2B Market Drivers in Global Market
Table 84. Glutamate Receptor Ionotropic NMDA 2B Market Restraints in Global Market
Table 85. Glutamate Receptor Ionotropic NMDA 2B Raw Materials
Table 86. Glutamate Receptor Ionotropic NMDA 2B Raw Materials Suppliers in Global Market
Table 87. Typical Glutamate Receptor Ionotropic NMDA 2B Downstream
Table 88. Glutamate Receptor Ionotropic NMDA 2B Downstream Clients in Global Market
Table 89. Glutamate Receptor Ionotropic NMDA 2B Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Glutamate Receptor Ionotropic NMDA 2B Segment by Type in 2022
Figure 2. Glutamate Receptor Ionotropic NMDA 2B Segment by Application in 2022
Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Glutamate Receptor Ionotropic NMDA 2B Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2018-2029 (US$, Mn)
Figure 7. Glutamate Receptor Ionotropic NMDA 2B Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Glutamate Receptor Ionotropic NMDA 2B Revenue in 2022
Figure 9. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 11. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 12. By Type - Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 15. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 16. By Application - Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 20. By Region - Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 21. By Country - North America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 22. By Country - North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 23. US Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 28. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 29. France Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 37. China Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 41. India Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 43. By Country - South America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 44. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2018-2029
Figure 48. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$, Mn), 2018-2029
Figure 52. Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Glutamate Receptor Ionotropic NMDA 2B by Region, 2022 VS 2029
Figure 54. Glutamate Receptor Ionotropic NMDA 2B Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ イオンチャネル型グルタミン酸受容体NMDA 2Bの世界市場見通し2023年-2029年(Glutamate Receptor Ionotropic NMDA 2B Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 代謝型グルタミン酸受容体1型の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆